Literature DB >> 11952587

Fate of the rectum in patients undergoing total colectomy for Crohn's disease.

P Cattan1, N Bonhomme, Y Panis, M Lémann, B Coffin, Y Bouhnik, M Allez, E Sarfati, P Valleur.   

Abstract

BACKGROUND: This study aimed to analyse disease recurrence and fate of the rectum in patients who had a total colectomy for Crohn's disease.
METHODS: One hundred and forty-four patients who had a total colectomy for Crohn's colitis were reviewed retrospectively. Ileorectal anastomosis (IRA) was performed in 118 patients, while 26 never had an IRA after colectomy because of severe anorectal lesions. Factors associated with recurrence and rectal preservation failure were studied.
RESULTS: The probability of clinical recurrence after IRA was 58 and 83 per cent at 5 and 10 years respectively. The probability of rectal preservation at 5 and 10 years was 70 and 63 per cent after colectomy, and 86 and 86 per cent after IRA, respectively. Patients with extraintestinal manifestation had a higher risk of recurrence and of rectal preservation failure. Previous ileal involvement was associated with a higher rate of ileal recurrence after IRA. After IRA, prophylactic treatment with 5-aminosalicylic acid was associated with a lower rate of recurrence and of failure to preserve the rectum.
CONCLUSION: Overall, 63 per cent of patients had a functioning IRA 10 years after total colectomy. Absence of extraintestinal manifestation and prophylactic treatment with 5-aminosalicylates after IRA were the main factors associated with long-term rectal preservation.

Entities:  

Mesh:

Year:  2002        PMID: 11952587     DOI: 10.1046/j.0007-1323.2001.02053.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  10 in total

Review 1.  Surgery for luminal Crohn's disease.

Authors:  Takayuki Yamamoto; Toshiaki Watanabe
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

Review 2.  Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): Crohn's disease.

Authors:  G Pellino; D S Keller; G M Sampietro; I Angriman; M Carvello; V Celentano; F Colombo; F Di Candido; S Laureti; G Luglio; G Poggioli; M Rottoli; S Scaringi; G Sciaudone; G Sica; L Sofo; S Leone; S Danese; A Spinelli; G Delaini; F Selvaggi
Journal:  Tech Coloproctol       Date:  2020-03-14       Impact factor: 3.781

Review 3.  Reoperative Surgery in Complex Crohn's Disease.

Authors:  Jennifer A Leinicke; David W Dietz
Journal:  Clin Colon Rectal Surg       Date:  2019-07-02

4.  Risk factors for proctectomy in consecutive Crohn's colitis surgical patients in a reference colorectal centre.

Authors:  Gisele Aaltonen; Monika Carpelan-Holmström; Ilona Keränen; Anna Lepistö
Journal:  Int J Colorectal Dis       Date:  2019-06-28       Impact factor: 2.571

Review 5.  Restorative procedures in colonic crohn disease.

Authors:  Sean T Martin; Jon D Vogel
Journal:  Clin Colon Rectal Surg       Date:  2013-06

6.  Reoperative inflammatory bowel disease surgery.

Authors:  Rowena L Ramirez; Phillip Fleshner
Journal:  Clin Colon Rectal Surg       Date:  2006-11

7.  Colonic Crohn's disease.

Authors:  Steven Mills; Michael J Stamos
Journal:  Clin Colon Rectal Surg       Date:  2007-11

Review 8.  Surgical treatment of perianal fistulizing Crohn's disease: from lay-open to cell-based therapy--an overview.

Authors:  Gianluca Pellino; Francesco Selvaggi
Journal:  ScientificWorldJournal       Date:  2014-11-06

Review 9.  Management of complex perianal Crohn's disease.

Authors:  Lara Aguilera-Castro; Carlos Ferre-Aracil; Ana Garcia-Garcia-de-Paredes; Enrique Rodriguez-de-Santiago; Antonio Lopez-Sanroman
Journal:  Ann Gastroenterol       Date:  2016-10-27

10.  Restoration of intestinal continuity after stoma formation for Crohn's disease in the era of biological therapy : A retrospective cohort study.

Authors:  Catharina Müller; Michael Bergmann; Anton Stift; Stanislaus Argeny; Doug Speake; Lukas Unger; Stefan Riss
Journal:  Wien Klin Wochenschr       Date:  2020-01-08       Impact factor: 1.704

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.